Randomized, Controlled, Multicenter Comparative Trial to Evaluate for the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) In Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments

Principal Investigator 

Celso Tello, M.D.

Objective

The Gold Shunt is a Randomized, controlled, multi center trial to evaluate the Solx Gold Shunt for the reduction of Intra Ocular Pressure (IOP) in Glaucomatous eyes following failed medical and conventional surgical treatments.

Eligibility

To Be eligible for the trial you must be older than 18 years old, IOP higher than 22 and 23 ,have a failed trabeculectomy, be compliant with your appointments, and follow ups , and be willing to sign a consent to be follow for at least 2 years, VA of 20 /40 or worse.

Enrollment Goal

20 participants (OPEN)

Contact Information

Oliver Antequera M.D
2124777540 Ext 303
2128148230 Ext 4884
Oantequera@NYEE.EDU

 

Home > Current Research > Clinical Trials in Ophthalmology > Randomized, Controlled, Multicenter Comparative Trial to Evaluate for the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) In Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments